Symbol:
Mindy2
Name:
MINDY lysine 48 deubiquitinase 2
RGD ID:
1311456
Description:
Predicted to enable peptidase activity and polyubiquitin modification-dependent protein binding activity. Predicted to be involved in chromatin remodeling and proteolysis. Predicted to be located in nucleoplasm. Orthologous to human MINDY2 (MINDY lysine 48 deubiquitinase 2); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 4,4'-sulfonyldiphenol; bisphenol A.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
Fam63b; family with sequence similarity 63, member B; LOC363089; RGD1311456; similar to RIKEN cDNA B230380D07; ubiquitin carboxyl-terminal hydrolase MINDY-2
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 8 80,149,127 - 80,210,011 (-) NCBI GRCr8 mRatBN7.2 8 71,268,274 - 71,327,698 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 8 71,256,447 - 71,328,453 (-) Ensembl mRatBN7.2 Ensembl Rnor_6.0 8 77,029,346 - 77,089,208 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 8 77,035,147 - 77,089,097 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 8 75,992,850 - 76,053,316 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 8 75,078,181 - 75,134,060 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 8 75,097,535 - 75,153,071 (-) NCBI Celera 8 70,401,551 - 70,460,881 (+) NCBI Celera Cytogenetic Map 8 q24 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Mindy2 Rat (-)-alpha-phellandrene increases expression ISO MINDY2 (Homo sapiens) 6480464 alpha phellandrene results in increased expression of MINDY2 mRNA CTD PMID:25075043 Mindy2 Rat 1,2-dimethylhydrazine multiple interactions ISO Mindy2 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MINDY2 mRNA CTD PMID:22206623 Mindy2 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of MINDY2 mRNA CTD PMID:22298810 Mindy2 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Mindy2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to MINDY2 promoter] CTD PMID:19654925 Mindy2 Rat 4,4'-sulfonyldiphenol decreases expression ISO Mindy2 (Mus musculus) 6480464 bisphenol S results in decreased expression of MINDY2 mRNA CTD PMID:39298647 Mindy2 Rat 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of MINDY2 mRNA CTD PMID:36041667 Mindy2 Rat aflatoxin B1 increases expression ISO Mindy2 (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of MINDY2 mRNA CTD PMID:19770486 Mindy2 Rat alpha-phellandrene increases expression ISO MINDY2 (Homo sapiens) 6480464 alpha phellandrene results in increased expression of MINDY2 mRNA CTD PMID:25075043 Mindy2 Rat aristolochic acid A decreases expression ISO MINDY2 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of MINDY2 mRNA CTD PMID:33212167 Mindy2 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MINDY2 mRNA CTD PMID:25181051 Mindy2 Rat bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of MINDY2 mRNA CTD PMID:36041667 Mindy2 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of MINDY2 mRNA CTD PMID:34947998 Mindy2 Rat bisphenol A decreases expression ISO MINDY2 (Homo sapiens) 6480464 bisphenol A results in decreased expression of MINDY2 mRNA CTD PMID:27685785 Mindy2 Rat bisphenol F increases expression ISO Mindy2 (Mus musculus) 6480464 bisphenol F results in increased expression of MINDY2 mRNA CTD PMID:38685157 Mindy2 Rat bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of MINDY2 mRNA CTD PMID:36041667 Mindy2 Rat caffeine affects phosphorylation ISO MINDY2 (Homo sapiens) 6480464 Caffeine affects the phosphorylation of MINDY2 protein CTD PMID:35688186 Mindy2 Rat carbon nanotube decreases expression ISO Mindy2 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 and PMID:25620056 Mindy2 Rat chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of MINDY2 mRNA CTD PMID:23125180 Mindy2 Rat chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of MINDY2 mRNA CTD PMID:18668222 Mindy2 Rat cisplatin decreases expression ISO MINDY2 (Homo sapiens) 6480464 Cisplatin results in decreased expression of MINDY2 mRNA CTD PMID:27392435 Mindy2 Rat clofibrate decreases expression ISO Mindy2 (Mus musculus) 6480464 Clofibrate results in decreased expression of MINDY2 mRNA CTD PMID:23811191 Mindy2 Rat DDE decreases expression ISO MINDY2 (Homo sapiens) 6480464 Dichlorodiphenyl Dichloroethylene results in decreased expression of MINDY2 mRNA CTD PMID:38568856 Mindy2 Rat diuron increases expression EXP 6480464 Diuron results in increased expression of MINDY2 mRNA CTD PMID:25152437 Mindy2 Rat doxorubicin decreases expression ISO MINDY2 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of MINDY2 mRNA CTD PMID:29803840 Mindy2 Rat flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of MINDY2 mRNA CTD PMID:24793618 Mindy2 Rat folic acid multiple interactions ISO Mindy2 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MINDY2 mRNA CTD PMID:22206623 Mindy2 Rat FR900359 decreases phosphorylation ISO MINDY2 (Homo sapiens) 6480464 FR900359 results in decreased phosphorylation of MINDY2 protein CTD PMID:37730182 Mindy2 Rat indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of MINDY2 mRNA CTD PMID:21396975 Mindy2 Rat lipopolysaccharide multiple interactions ISO MINDY2 (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 Mindy2 Rat lipopolysaccharide decreases expression ISO MINDY2 (Homo sapiens) 6480464 Lipopolysaccharides results in decreased expression of MINDY2 mRNA CTD PMID:35811015 Mindy2 Rat methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of MINDY2 mRNA CTD PMID:19564919 Mindy2 Rat methylmercury chloride decreases expression ISO MINDY2 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of MINDY2 mRNA CTD PMID:28001369 Mindy2 Rat miconazole decreases expression ISO Mindy2 (Mus musculus) 6480464 Miconazole results in decreased expression of MINDY2 mRNA CTD PMID:27462272 Mindy2 Rat phenobarbital decreases expression ISO Mindy2 (Mus musculus) 6480464 Phenobarbital results in decreased expression of MINDY2 mRNA CTD PMID:23091169 Mindy2 Rat pirinixic acid multiple interactions ISO MINDY2 (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of MINDY2 mRNA CTD PMID:19710929 Mindy2 Rat pirinixic acid decreases expression ISO Mindy2 (Mus musculus) 6480464 pirinixic acid results in decreased expression of MINDY2 mRNA CTD PMID:23811191 Mindy2 Rat propiconazole decreases expression ISO Mindy2 (Mus musculus) 6480464 propiconazole results in decreased expression of MINDY2 mRNA CTD PMID:21278054 Mindy2 Rat resveratrol multiple interactions ISO MINDY2 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of MINDY2 mRNA CTD PMID:23557933 Mindy2 Rat S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO MINDY2 (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 Mindy2 Rat sodium arsenate increases expression ISO Mindy2 (Mus musculus) 6480464 sodium arsenate results in increased expression of MINDY2 mRNA CTD PMID:21795629 Mindy2 Rat sodium arsenite decreases expression ISO MINDY2 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of MINDY2 mRNA CTD PMID:28595984 and PMID:34032870 Mindy2 Rat sodium arsenite increases expression ISO MINDY2 (Homo sapiens) 6480464 sodium arsenite results in increased expression of MINDY2 mRNA CTD PMID:38568856 Mindy2 Rat Soman decreases expression EXP 6480464 Soman results in decreased expression of MINDY2 mRNA CTD PMID:19281266 Mindy2 Rat succimer multiple interactions ISO Mindy2 (Mus musculus) 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MINDY2 mRNA CTD PMID:21641980 Mindy2 Rat thiram increases expression ISO MINDY2 (Homo sapiens) 6480464 Thiram results in increased expression of MINDY2 mRNA CTD PMID:38568856 Mindy2 Rat triphenyl phosphate affects expression ISO MINDY2 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of MINDY2 mRNA CTD PMID:37042841 Mindy2 Rat troglitazone decreases expression ISO Mindy2 (Mus musculus) 6480464 troglitazone results in decreased expression of MINDY2 mRNA CTD PMID:28973697 Mindy2 Rat valproic acid affects expression ISO MINDY2 (Homo sapiens) 6480464 Valproic Acid affects the expression of MINDY2 mRNA CTD PMID:25979313 Mindy2 Rat valproic acid affects expression ISO Mindy2 (Mus musculus) 6480464 Valproic Acid affects the expression of MINDY2 mRNA CTD PMID:17292431 Mindy2 Rat valproic acid decreases expression ISO MINDY2 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of MINDY2 mRNA CTD PMID:26272509 Mindy2 Rat valproic acid increases expression ISO Mindy2 (Mus musculus) 6480464 Valproic Acid results in increased expression of MINDY2 mRNA CTD PMID:19136453 and PMID:21427059 Mindy2 Rat vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of MINDY2 mRNA CTD PMID:19015723
(-)-alpha-phellandrene (ISO) 1,2-dimethylhydrazine (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 4,4'-sulfonyldiphenol (EXP,ISO) aflatoxin B1 (ISO) alpha-phellandrene (ISO) aristolochic acid A (ISO) bisphenol A (EXP,ISO) bisphenol F (EXP,ISO) caffeine (ISO) carbon nanotube (ISO) chloroprene (EXP) chlorpyrifos (EXP) cisplatin (ISO) clofibrate (ISO) DDE (ISO) diuron (EXP) doxorubicin (ISO) flutamide (EXP) folic acid (ISO) FR900359 (ISO) indole-3-methanol (EXP) lipopolysaccharide (ISO) methamphetamine (EXP) methylmercury chloride (ISO) miconazole (ISO) phenobarbital (ISO) pirinixic acid (ISO) propiconazole (ISO) resveratrol (ISO) S-(1,2-dichlorovinyl)-L-cysteine (ISO) sodium arsenate (ISO) sodium arsenite (ISO) Soman (EXP) succimer (ISO) thiram (ISO) triphenyl phosphate (ISO) troglitazone (ISO) valproic acid (ISO) vinclozolin (EXP)
Mindy2 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 8 80,149,127 - 80,210,011 (-) NCBI GRCr8 mRatBN7.2 8 71,268,274 - 71,327,698 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 8 71,256,447 - 71,328,453 (-) Ensembl mRatBN7.2 Ensembl Rnor_6.0 8 77,029,346 - 77,089,208 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 8 77,035,147 - 77,089,097 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 8 75,992,850 - 76,053,316 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 8 75,078,181 - 75,134,060 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 8 75,097,535 - 75,153,071 (-) NCBI Celera 8 70,401,551 - 70,460,881 (+) NCBI Celera Cytogenetic Map 8 q24 NCBI
MINDY2 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 15 58,771,302 - 58,861,900 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 15 58,771,192 - 58,861,900 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 15 59,063,501 - 59,154,099 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 15 56,850,685 - 56,937,046 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Celera 15 35,951,332 - 36,037,699 (+) NCBI Celera Cytogenetic Map 15 q21.3-q22.1 NCBI HuRef 15 35,885,953 - 35,972,658 (+) NCBI HuRef CHM1_1 15 59,181,343 - 59,267,684 (+) NCBI CHM1_1 T2T-CHM13v2.0 15 56,573,291 - 56,663,918 (+) NCBI T2T-CHM13v2.0
Mindy2 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 9 70,506,296 - 70,566,429 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 9 70,506,296 - 70,564,456 (-) Ensembl GRCm39 Ensembl GRCm38 9 70,599,014 - 70,657,856 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 9 70,599,014 - 70,657,174 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 9 70,446,821 - 70,504,981 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 9 70,403,759 - 70,456,322 (-) NCBI MGSCv36 mm8 Celera 9 67,815,959 - 67,874,302 (-) NCBI Celera Cytogenetic Map 9 D NCBI cM Map 9 39.53 NCBI
Mindy2 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955450 15,753,892 - 15,808,205 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955450 15,753,892 - 15,808,205 (-) NCBI ChiLan1.0 ChiLan1.0
MINDY2 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 16 48,032,402 - 48,126,098 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 15 52,214,742 - 52,308,610 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 15 37,737,665 - 37,831,501 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 15 56,047,970 - 56,141,490 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 15 56,047,970 - 56,134,203 (+) Ensembl panpan1.1 panPan2
MINDY2 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 30 23,753,566 - 23,827,586 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 30 23,753,681 - 23,821,254 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 30 23,727,565 - 23,801,409 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 30 23,921,729 - 23,995,834 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 30 23,920,848 - 23,992,842 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 30 23,845,519 - 23,919,360 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 30 23,930,500 - 24,004,340 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 30 24,073,982 - 24,147,852 (+) NCBI UU_Cfam_GSD_1.0
Mindy2 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024408640 102,089,417 - 102,171,572 (+) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936471 19,937,254 - 20,012,777 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936471 19,937,550 - 20,015,138 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
MINDY2 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 1 113,176,223 - 113,258,648 (-) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 1 113,171,047 - 113,258,761 (-) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 1 125,244,057 - 125,294,523 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
MINDY2 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 26 24,662,351 - 24,747,383 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 26 24,664,998 - 24,746,225 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666048 116,573,624 - 116,655,815 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Mindy2 (Heterocephalus glaber - naked mole-rat)
.
1298065 Scl16 Serum cholesterol level QTL 16 3.8 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 8 30856404 75856404 Rat 1554321 Bmd3 Bone mineral density QTL 3 7.9 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 8 40952565 123900184 Rat 1578769 Uae31 Urinary albumin excretion QTL 31 3.3 0.001 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 8 30848154 101699754 Rat 1298079 Activ2 Activity QTL 2 9.5 0.000001 voluntary movement trait (VT:0003491) rearing measurement (CMO:0001515) 8 41866876 86866876 Rat 70161 Bp62 Blood pressure QTL 62 2.9 0.001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 8 42692684 90165460 Rat 1578765 Klgr1 Kidney lesion grade QTL 1 3.3 0.0001 kidney morphology trait (VT:0002135) organ lesion measurement (CMO:0000677) 8 30848154 101699754 Rat 1582222 Epfw2 Epididymal fat weight QTL 2 3.2 0.0005 epididymal fat pad mass (VT:0010421) epididymal fat pad weight to body weight ratio (CMO:0000658) 8 31737729 76737729 Rat 61464 Niddm11 Non-insulin dependent diabetes mellitus QTL 11 3.1 0.001 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 8 35582032 80582032 Rat 4889938 Bss89 Bone structure and strength QTL 89 3.8 tibia size trait (VT:0100001) tibia cortical bone volume (CMO:0001725) 8 50095249 82460899 Rat 1578755 Pur5 Proteinuria QTL 5 3.3 0.0001 urine total protein amount (VT:0000032) urine total protein excretion rate (CMO:0000756) 8 30848154 101699754 Rat 1300146 Rf17 Renal function QTL 17 2.9 renal blood flow trait (VT:2000006) absolute change in renal blood flow rate (CMO:0001168) 8 28242912 73242912 Rat 8662823 Vetf5 Vascular elastic tissue fragility QTL 5 1.9 artery integrity trait (VT:0010639) patent ductus arteriosus score (CMO:0002566) 8 28242912 99525068 Rat 2313088 Bss75 Bone structure and strength QTL 75 3.1 0.0001 body length (VT:0001256) body length, nose to rump (CMO:0000079) 8 30848154 82460899 Rat 631210 Bw3 Body weight QTL3 5.9 mesenteric fat pad mass (VT:0010427) mesenteric fat pad weight to body weight ratio (CMO:0000654) 8 69349194 112783834 Rat 1358896 Bp262 Blood pressure QTL 262 2.89 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 8 27205715 99103503 Rat 731182 Uae24 Urinary albumin excretion QTL 24 6.4 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 8 19331152 93965294 Rat 737824 Hcar10 Hepatocarcinoma resistance QTL 10 2.9 liver integrity trait (VT:0010547) liver tumorous lesion number (CMO:0001068) 8 40713066 82925667 Rat 1331769 Rf39 Renal function QTL 39 3.871 urine output (VT:0003620) timed urine volume (CMO:0000260) 8 41866876 75097878 Rat 61358 Bp39 Blood pressure QTL 39 2 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 8 35551938 80551938 Rat 1358906 Bp253 Blood pressure QTL 253 4 0.0004 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 8 40713066 93965294 Rat 1358907 Cm40 Cardiac mass QTL 40 1.89 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 8 27205715 99103503 Rat 70197 BpQTLcluster8 Blood pressure QTL cluster 8 3.482 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 8 46531639 119088626 Rat 2316950 Scl66 Serum cholesterol level QTL 66 4.1 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 8 30848259 105647037 Rat 1582254 Kidm31 Kidney mass QTL 31 3 kidney mass (VT:0002707) both kidneys wet weight (CMO:0000085) 8 54237644 85365202 Rat 10402857 Bp380 Blood pressure QTL 380 0.95 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 8 53968765 98968765 Rat 1358892 Kidm26 Kidney mass QTL 26 3.69 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 8 27205715 99103503 Rat 5684973 Bss100 Bone structure and strength QTL 100 4.7 tibia area (VT:1000281) tibia area measurement (CMO:0001382) 8 50095249 82460899 Rat 1582243 Bw66 Body weight QTL 66 3.4 0.0048 body mass (VT:0001259) body weight (CMO:0000012) 8 54237644 85365202 Rat 2313057 Bss76 Bone structure and strength QTL 76 3 0.0001 tibia size trait (VT:0100001) tibia midshaft cross-sectional area (CMO:0001717) 8 30848154 82460899 Rat 12879878 Bw183 Body weight QTL 183 0.001 body mass (VT:0001259) body weight (CMO:0000012) 8 43296169 98968765 Rat 1300177 Cm2 Cardiac mass QTL 2 3.65 heart mass (VT:0007028) heart weight (CMO:0000017) 8 54259986 100382532 Rat 1549908 Neudeg1 Neurodegradation QTL 1 5.5 0 nervous system integrity trait (VT:0010566) logarithm of the ratio of the lesioned side motor neuron count to contralateral side motor neuron count (CMO:0001986) 8 30188867 94457446 Rat 12879879 Cm99 Cardiac mass QTL 99 0.001 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 8 43296169 98968765 Rat 2313067 Bss77 Bone structure and strength QTL 77 3.1 0.0001 tibia size trait (VT:0100001) tibia midshaft endosteal cross-sectional area (CMO:0001716) 8 30848154 82460899 Rat 12879880 Cm100 Cardiac mass QTL 100 0.001 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 8 43296169 98968765 Rat 12879881 Cm101 Cardiac mass QTL 101 0.001 heart right ventricle mass (VT:0007033) heart right ventricle weight to body weight ratio (CMO:0000914) 8 43296169 98968765 Rat 12879882 Am8 Aortic mass QTL 8 0.001 aorta mass (VT:0002845) aorta weight to aorta length to body weight ratio (CMO:0002722) 8 43296169 98968765 Rat 12879883 Kidm65 Kidney mass QTL 65 0.001 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 8 43296169 98968765 Rat 1358912 Bw51 Body weight QTL 51 2.95 body mass (VT:0001259) body weight (CMO:0000012) 8 51351728 107062046 Rat 1300171 Bp184 Blood pressure QTL 184 3.66 arterial blood pressure trait (VT:2000000) blood pressure time series experimental set point of the baroreceptor response (CMO:0002593) 8 70513503 118219066 Rat 2313086 Bss60 Bone structure and strength QTL 60 4.1 0.0001 tibia length (VT:0004357) tibia length (CMO:0000450) 8 50095249 82460899 Rat 2303171 Bp331 Blood pressure QTL 331 5.57 0.005 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 8 61290298 119084929 Rat 2293697 Bmd39 Bone mineral density QTL 39 femur strength trait (VT:0010010) femur total energy absorbed before break (CMO:0001677) 8 54043744 98968765 Rat 1331837 Bw23 Body weight QTL 23 4.19 0.00007 body mass (VT:0001259) body weight (CMO:0000012) 8 46531722 99083736 Rat 1331838 Niddm61 Non-insulin dependent diabetes mellitus QTL 61 3.53 0.0004 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 8 36469535 99083736 Rat 631650 Stl6 Serum triglyceride level QTL 6 4 0.0019 blood triglyceride amount (VT:0002644) plasma triglyceride level (CMO:0000548) 8 10378157 112202585 Rat 631653 Bp125 Blood pressure QTL 125 3.3 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 8 66142385 111142385 Rat 1581557 Eae16 Experimental allergic encephalomyelitis QTL 16 3.8 nervous system integrity trait (VT:0010566) experimental autoimmune encephalomyelitis incidence/prevalence measurement (CMO:0001046) 8 8462195 110921472 Rat 631271 Lecl1 Lens clarity QTL 1 0.001 lens clarity trait (VT:0001304) age of onset/diagnosis of cataract (CMO:0001584) 8 18984168 84531599 Rat 2303570 Gluco48 Glucose level QTL 48 2 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 8 49805831 94805831 Rat 2313046 Bss78 Bone structure and strength QTL 78 3.5 0.0001 tibia strength trait (VT:1000284) tibia total energy absorbed before break (CMO:0001736) 8 30848154 82460899 Rat 2301402 Bp316 Blood pressure QTL 316 0.005 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 8 53968765 98968765 Rat 631664 Hcar3 Hepatocarcinoma resistance QTL 3 2.9 0.0005 liver integrity trait (VT:0010547) volume of individual liver tumorous lesion (CMO:0001078) 8 54237644 99103503 Rat
D8Got339
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 8 71,306,607 - 71,306,744 (+) MAPPER mRatBN7.2 Rnor_6.0 8 77,068,591 - 77,068,727 NCBI Rnor6.0 Rnor_5.0 8 76,014,001 - 76,014,137 UniSTS Rnor5.0 RGSC_v3.4 8 75,111,992 - 75,112,128 UniSTS RGSC3.4 Celera 8 70,422,476 - 70,422,612 UniSTS Cytogenetic Map 8 q24 UniSTS
AI232149
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 8 71,273,555 - 71,273,749 (+) MAPPER mRatBN7.2 Rnor_6.0 8 77,034,628 - 77,034,821 NCBI Rnor6.0 Rnor_5.0 8 76,047,841 - 76,048,034 UniSTS Rnor5.0 RGSC_v3.4 8 75,078,351 - 75,078,544 UniSTS RGSC3.4 Celera 8 70,455,406 - 70,455,599 UniSTS Cytogenetic Map 8 q24 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000078685 ⟹ ENSRNOP00000070456
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 8 71,273,646 - 71,328,453 (-) Ensembl Rnor_6.0 Ensembl 8 77,035,147 - 77,089,097 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000094906 ⟹ ENSRNOP00000083544
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 8 71,273,646 - 71,328,453 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000119592 ⟹ ENSRNOP00000082611
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 8 71,256,447 - 71,328,453 (-) Ensembl
RefSeq Acc Id:
XM_017596087 ⟹ XP_017451576
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 80,155,158 - 80,210,011 (-) NCBI mRatBN7.2 8 71,274,258 - 71,327,417 (-) NCBI Rnor_6.0 8 77,035,809 - 77,089,208 (-) NCBI
Sequence:
AAGCGGGAGGGGCGTGGCCTCGGGGGAAGAAGCGCTCCCTGAGTGGGTCGGAGCGTCTCACGGAGCACAGTCACGCGGAGGCACGCTCCGAGCGAGCGGGCGAGAGCTCGCGAGCGCGCTCCCGCCGC CCTCTACGGTGACGTGCCTGGCCGAGGCCGCGCTAGGGCGCTGGAGCTGCTACAGAGCCGCTGTCATGGCGTCGGAGGCGCTAGCTGAGGAGAGCCGGCCGCGGTGTCTATAGGACCAGGGACGGGCG GCCGGGGATGGAGAACGGCCCTGACAGCCCACAGCCTTTGGAACTCGGGGTGCCAGCGGGGCGAGTGTCAACGCCGGAAGGGCGACGGCGCGACGGGCGCGAGGCTGAGGATGGTCCCGCTGGACGAG CGGTGGACAGCGGCGGGCAGGGGGCGGCGGCAGCGCGTAGCAGTCTCGGGGACCCGACGTCTCCCTCGCAGCACGGATGCAGCGCGGGCTCGGACTTGAAGAACAGCGCGTCGTCGAGCCCGGTCGCC TCGGAGGCGCCTTCAAGAGGGCAGCACAAGGTGACCGCCTCCCCGGAGCTGGCCGAGGCCGCGGCGGGCCGAGGGTCCGGGCCAGTGGGTGACACAGGCACCTGCAGGGTGGAGCAGGCGGCGGAGGA GCCCAGCAGCGCTGGCGCCCTGAGCAGCAGCTGCAGCGAGCCGAGCCCCCCTGGGGACTCGCCTAGCTTGGACTCCCTGGAGTCTTTCTCCAACCTGCATTCTTTCCCCAGTAGCTCTGAGTTCAATA GCGAGGAGGGAGCGGAGACCAGGGTCCCCGAGGACGTGGAGGAGGGCGCGGCGGAGCCGCCCAGGGTTGCACCTCTGTGCAAAGAGGAGGAGGAGGACCCGGCTCAGGTGCTGGCAGCCTCCAAAGAA CGCTTTCCGGGACAGTCAGTGTATCACATCAAATGGATCCAGTGGAAAGAGGAGAACACGCCCATCATCACCCAGAATGAGAATGGACCCTGCCCATTGCTGGCTATCCTCAATGTTTTGCTTCTCGC CTGGAAGGTGAAACTCCCACCGATGATGGAGATCATAACCGCGGAGCAGCTGATGGAGTATCTCGGCGATTACATGCTTGAGGCAAAGCCAAAAGAAATCTCAGAAATTCAACGTGTAAATTATGAAC AGAATATGAGCGATGCTATGGCAATCTTGCACAAACTGCAGACAGGCCTGGATGTGAATGTCAGGTTCACTGGGGTACGAGTTTTCGAGTACACACCAGAGTGCATAGTCTTTGATCTTCTAGATATT CCTTTGTATCATGGGTGGTTAGTGGACCCTCAGATCGATGACATTGTAAGAGCTGTTGGCAACTGCAGCTACAACCAGCTGGTGGAGAAGATCATCTCCTGTAAGCAGTCGGACAACAGCCAGTTGGT TAGTGAAGGCTTTGTAGCTGAGCAGTTTCTAAACAATACAGCCACTCAACTGACGTACCATGGATTATGTGAACTGACTTCAACGGTTCAGGAAGGAGAACTCTGTGTGTTCTTTCGGAATAATCATT TTAGCACCATGACAAAATACAAGGGTCAACTGTATTTGTTGGTAACAGACCAGGGCTTTCTTACTGAAGAAAAAATTGTCTGGGAAAGCCTCCACAATGTAGATGGCGATGGAAATTTCTGTGACTCA GAATTCCGTCTTCGGCCTCCTTCAGATCCTGAGACTGTATACAAAGGTCAACAAGACCAAATAGATCAAGACTACCTTATGGCACTGTCACTGCAACAAGAACAGCAGAGCCAAGACATCAACTGGGA GCAAATCCCAGAAGGAATCAGTGACTTGGAGTTGGCAAAGAAACTCCAGGAAGAGGAGGACCGACGGGCCTCTCAGTACTACCAGGAGCAGGAGCAGGCTCAGGCTGCTGTGGCCACCACCACCCCTT CCACGCAGGCCCAGAAGCAACTTAGAGAAGAAAGGTTTGTTGTGACTTACGGTAGAGGGTGCAGTTCATCATGGTCATGAAGACATGGCTGATGGAG
hide sequence
RefSeq Acc Id:
XM_039082503 ⟹ XP_038938431
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 80,159,517 - 80,210,011 (-) NCBI mRatBN7.2 8 71,278,582 - 71,327,698 (-) NCBI
RefSeq Acc Id:
XM_343420 ⟹ XP_343421
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 80,149,127 - 80,210,011 (-) NCBI mRatBN7.2 8 71,268,274 - 71,327,417 (-) NCBI Rnor_6.0 8 77,029,346 - 77,089,205 (-) NCBI Rnor_5.0 8 75,992,850 - 76,053,316 (+) NCBI RGSC_v3.4 8 75,078,181 - 75,134,060 (-) RGD
Sequence:
CGGGAGGGGCGTGGCCTCGGGGGAAGAAGCGCTCCCTGAGTGGGTCGGAGCGTCTCACGGAGCACAGTCACGCGGAGGCACGCTCCGAGCGAGCGGGCGAGAGCTCGCGAGCGCGCTCCCGCCGCCCT CTACGGTGACGTGCCTGGCCGAGGCCGCGCTAGGGCGCTGGAGCTGCTACAGAGCCGCTGTCATGGCGTCGGAGGCGCTAGCTGAGGAGAGCCGGCCGCGGTGTCTATAGGACCAGGGACGGGCGGCC GGGGATGGAGAACGGCCCTGACAGCCCACAGCCTTTGGAACTCGGGGTGCCAGCGGGGCGAGTGTCAACGCCGGAAGGGCGACGGCGCGACGGGCGCGAGGCTGAGGATGGTCCCGCTGGACGAGCGG TGGACAGCGGCGGGCAGGGGGCGGCGGCAGCGCGTAGCAGTCTCGGGGACCCGACGTCTCCCTCGCAGCACGGATGCAGCGCGGGCTCGGACTTGAAGAACAGCGCGTCGTCGAGCCCGGTCGCCTCG GAGGCGCCTTCAAGAGGGCAGCACAAGGTGACCGCCTCCCCGGAGCTGGCCGAGGCCGCGGCGGGCCGAGGGTCCGGGCCAGTGGGTGACACAGGCACCTGCAGGGTGGAGCAGGCGGCGGAGGAGCC CAGCAGCGCTGGCGCCCTGAGCAGCAGCTGCAGCGAGCCGAGCCCCCCTGGGGACTCGCCTAGCTTGGACTCCCTGGAGTCTTTCTCCAACCTGCATTCTTTCCCCAGTAGCTCTGAGTTCAATAGCG AGGAGGGAGCGGAGACCAGGGTCCCCGAGGACGTGGAGGAGGGCGCGGCGGAGCCGCCCAGGGTTGCACCTCTGTGCAAAGAGGAGGAGGAGGACCCGGCTCAGGTGCTGGCAGCCTCCAAAGAACGC TTTCCGGGACAGTCAGTGTATCACATCAAATGGATCCAGTGGAAAGAGGAGAACACGCCCATCATCACCCAGAATGAGAATGGACCCTGCCCATTGCTGGCTATCCTCAATGTTTTGCTTCTCGCCTG GAAGGTGAAACTCCCACCGATGATGGAGATCATAACCGCGGAGCAGCTGATGGAGTATCTCGGCGATTACATGCTTGAGGCAAAGCCAAAAGAAATCTCAGAAATTCAACGTGTAAATTATGAACAGA ATATGAGCGATGCTATGGCAATCTTGCACAAACTGCAGACAGGCCTGGATGTGAATGTCAGGTTCACTGGGGTACGAGTTTTCGAGTACACACCAGAGTGCATAGTCTTTGATCTTCTAGATATTCCT TTGTATCATGGGTGGTTAGTGGACCCTCAGATCGATGACATTGTAAGAGCTGTTGGCAACTGCAGCTACAACCAGCTGGTGGAGAAGATCATCTCCTGTAAGCAGTCGGACAACAGCCAGTTGGTTAG TGAAGGCTTTGTAGCTGAGCAGTTTCTAAACAATACAGCCACTCAACTGACGTACCATGGATTATGTGAACTGACTTCAACGGTTCAGGAAGGAGAACTCTGTGTGTTCTTTCGGAATAATCATTTTA GCACCATGACAAAATACAAGGGTCAACTGTATTTGTTGGTAACAGACCAGGGCTTTCTTACTGAAGAAAAAATTGTCTGGGAAAGCCTCCACAATGTAGATGGCGATGGAAATTTCTGTGACTCAGAA TTCCGTCTTCGGCCTCCTTCAGATCCTGAGACTGTATACAAAGGTCAACAAGACCAAATAGATCAAGACTACCTTATGGCACTGTCACTGCAACAAGAACAGCAGAGCCAAGACATCAACTGGGAGCA AATCCCAGAAGGAATCAGTGACTTGGAGTTGGCAAAGAAACTCCAGGAAGAGGAGGACCGACGGGCCTCTCAGTACTACCAGGAGCAGGAGCAGGCTCAGGCTGCTGTGGCCACCACCACCCCTTCCA CGCAGGCCCAGCAGGGCCAGCCAGCGCAAGCCTCTCCATCAAGTATAAAACAGCCTGGGAATAGTGAACGGAAACGCAAGGAACCTCGGGAAAAAGACAAAGAGAAAGAAAAGGAAAAAAATAGCTGC GTGATTTTGTAGGGATTGCTGGCATCTGTGGGAACCACCTATGCAGATGACGGAAAGGAAGACCCAGTACCTACCGTCTGTGCCTGATCTCCCAATGGATTTTGCTCATGTTTTCCAGGGGAAAGTTG TTACTTTGTTACAATCAACTTTTTCAAGTTACACAATACATTCTTTATGAGCTGGAGTTTTATGTTACAAGTTGGAACTGTTGTGTGTTGTCACTGTAGCCAAATGAGTATATCACTCCTATTTTGTG TCTAGTGACATTGCAACTCAATCAGTTAGTAAGCTACTGTGTTCTATGTGACAATGGATGGAGGTCACTGAATGAGTTTGATCCTTCTCAAGATGTAATTATTAGCACAACTATGTCTGAACTTTACA TTGTTAAATTATGTTCTAATCCATGAGGAAAAAGGAGTTTAATACTGGGGAGGGGCAGCAGGAATAATGACCCTTCATTGTGCATTGAACTGGTTCAGCCCTTGAACAGCTTTACCTGTCTTTAGTAA TGCACATCTTAGCTATTATCTTGGGAACTGATAATGGAGCTTGGATCCAATTTAGATAGAAAAATATTTTTTATTTTCCAATAGCAAAAAAATAAAATACACGACACTAATACTTATAACCTATTCAG ATGAGATGCTGACTTTGTAGTGCTATGAGGTGTTGAGAAATTTCAGCACCTTCAGAGCCTGAAAGGTGGCTTCTGTTTGATGAGGATGTAATACGTGAGTGAGGAGAAGACCACACTCATGTTCAGCC TTGTAAATATAAGGACAGAGAAGAGCAGAGTTCACTGTCTACCTTTTTCTAGAATTACCTTGAACCTTAAATTTTAAATCATGTTTATTGCTAGAAATTTAAACCAATAAAAAGCACATTTCTGAAGG AGAGTTAATCTCTTGACTCTAATGAAAAGATATTAATAAAATTCTAAACATAGGTAGGAGTCTGAAGGAATTTATGTAAAAGCAATCAGATTTTTTAACTTATGAGAACCAAATGAACCTAAGACACC TTACATCATTTCTAGGATTCGGGGATATTTACTCAGCCTGGCGATGAGGCAGCACATACTGTATTTCTAGATACAATTTGGAAAACTGTCCTTCACATGCTTTATATACTTTGTATTTAGACTTTGTT TCAGTTATTTTTAAAGATTATTGCCAGTGCACAAAGCTGCGTGATTTATCCTAAACCTCAGTAAATTTTATTCAGGAGCATCACAGATTGAAAATCCAGTTAGAGAATATTTCTTGTGGTCTGGAAGC AACGAAAGACTACCAAAAGAAAGAAGTCTAGAGTTGAAGACTACTGTCATTGATGTTTTCCATGATCCCAAGCCGGCTGTAGGCTGAGTACATATGTAAAAAGTAGAGTTTTATTTATGAAAAGTCTT GTTCTAAGAGGAAAAGAACTTCAGGGCCACGCTGTACCTTTCTGTCCTTCTATAGTACCTATCTATTTATGCCCTTTGTTGTTTCTTTAGACTTTCTATACTAGCATGGGGACGAATCAGAGGACCTG CCTGGGGTATAACATTTGTGTGTAAAATACCTGATAAGTCTCTTAAGTGCAACCTAGAGTGAGTACGAACTGTCAGAGACCAGACCCCTTCAGATGGACTGACCTCAGCATAAACACCCATGACAGCA TTCTGCTGATTGGAGGAGAAAACGCAAACCTCAGAGTTTGCCTTTCCCAGATCAGTCTAATGTTTTAGTTTAGGAAACAGTTAACCTAAGAGATCAAGGCATATTTTTCCACAATTATATTACAATAT CTACTTATTGCCCTTGAAGATCTATATATAAAAGTTGTGTTATTTTTTACTCTCATATTTTTCCAAAGATAATAACTGCCAATACTATGTTCCCTTTAGAAGAAGGAAGAAATAGAACAGAAGGAACA CACACCACTCACTGAAAACCATCAGCGCTGCTGTCAGAGGAGTGGATGTGTGCTTAAAATCAGCAGTGTACTGTTCGTCAATCCAAACTGTTCTTACATGAGGTTCCCGAGTTGGGCTTGGCTACATT CCTGGAATTTAGTTTGATATGACAAGAGTCATATCAAACTTATTATAAGATGTTTGTTTTGATTACTGTGGGAGAGGTTAAATGTTTGACTCTATTAAAACAAATCTCTAAGATATGATTCCTGTCCT TGAAGGCTTGTCAAGGTTCCAAACTGCCACGTATTTATTTCCTGTGTTTGCTCAAGGCAGCAAGTGATCAATATTCAGGCATATTACTGCTTGTTTGGGCAAAGAGGACTTTGAAAATGGTGTTTTGA GGGATTTTCCCCCTTACAATACTTTGTGATATTGACATTGTTATACATATATTGCTAACACACGTTACAGTTTAAACATTTTGGAGCTTAATGATTCTAAATTCTGGGCACACTTGACTCATGTGCCA GTACAGCGGGAGAGCTAGCAGAAGGCAGGCAGGGAGCAGATATGGTCCCTGGCACTTTTCTCATACATTCAGAGCACACTAGTAAGGTTAGTGACCAGTCTGTATTAATGTGCACTTCTTCATTAGTA AGTCTGTTGCGTCAACAATGCTGTGACCTGTACTAGTTTATCAGTACCTAGAATCGTGTGTATGTCTCCATGACTTCTGTTTAGGCCTCAAAGCAATCTGAAAACTAACAGATTTAAAAGTTGTGAAT ATTTAAAAATATTCACACACACCTAGGAGTATCACCAAGTGGTACAGCATTTGCCTGCAGCACACAAAACCCTGGGTTCAATTCCTAGCATAAGTATGTAGACTCACTGGCAGCTAATCAGGGCACTG GCCTTATGCCCAGTCAGTGTGGATGGGAAGAATAACATCCTCCATGTCTCAAGGTCAGGCTAGGATTGAGCAAGTCAGAAGCTTAAGTTCAGAATTAGGTTCTAGAAGATGTAATAATATATATACTA TAATGTCAGATGTTAGTTGACTAAACTCAATGTTAGGCACTCTGTACTTGCACAAAAACTTCATAGCATTTGCTTTCCCTAAATCATAAACTCATTTCAGACCTGGAGGACCAGAGAGCATACGTGAG GGAAAGGCATGACTGTGATCACAAATGTCTGTAAAATCCTAGCAAATTAGGCAAGAATTTCTAGAACTGTCCTCAATCTTACTTAAATTTTAGACATAGTCTTGCTATATCTAGCCAGACTGGCTTGG AATCGACTGTTGTAGCCCAGGCTACCTTCAAACCCACAATCCTCCTGCCCCAGCTTCTCACTGCCACTACTACAGGTGGATATCACCATACCCAGCTTGTTGAAACTTCCTTTAGAAAAGCAAACAGC AAACTGATTACATGTTGCTTTGTGATTCATTGTACTGGTTATTTATTTTTTGACAGAAAGCTTACAGCCTTGTACCTAACACTGTCTTAGACATATAAATTGAAAAATTAATGTTTGACAAAATAAGG CAGAGACATTAAAGATAGCCACTTATTTATATTTTAAGGAATTAGACACGTGAAATTCTGGCTCATTTGGTGTTCGAAACCTGACTTTATCAGGGCATGGTAATACATACCTGTCATAGCGTTTTGTA GGGCTAAAGCAGGAGGATTCTAAGTTCAAGGCCACTCTGTGCAAATAATAAGACCCTGATTCTAAAACCAAACCTGACTTTGTCTTGTTTTGGCAATCATTGTGTGCCTCTGTTTACTCTGTGCAGGG TGCTCCTCTTCCCATGTATGCCCACAGTGCTTGGTTCTCCTGAGAAAAGGCCATACTTTAGCACTGAGAATTACCGAGATCATCACAGACACTGCACATTCTCCATTCTCGAGTGTGAAGACTTTTTA TAATGACTTAAATCAGTTTTTTATGCTGTTAGAATGTGTAGGATTCCTTTGAATGTGGCATCCTGGCTTTCAAAAATATTTTTTGCAGCTGCTTTTCTATTCAGCAGGCTAGTGTTGAGACCAGGAGT GTTTGGGCTTACAAAATGCACTTCACAGACCTGTCTTTCCAGTATCCTCCACAGATCTAGCTTTTAGAGCCCCTTGCTCAGTCCCTCCAGGGTAGAGCAATATCAGGAACTGACTTTGCTCTCCCCAC TGTTGTCAGTGTATACAGCTTATTTGTGGCTTTAAATGAACTCTGATCTTGTGCAAGTCAAATCCTTTAGACAGCAAGTGAAAAAACCCTAAAGGACCATGTGTGAACCTTAGCGTCCGTGGTTCTTG ATAAGTTAGCATCTTTTGTTACTGATGCTTGACATTTTTGAAACTGTTAAAGGGAAAAAAATTATGAAGAATTGAGTTTACTTTTCTTAGGTAACAGTTTAAAATAACTTTAAATTAAAAGCTCCCTA AAGGGAATAAATTACAGAGAAGACAAATCAGGAGGAAACCTTGCAGGATGCTGGAACAGTTACTTTGAAAATCTATCTAAAATTTAATTCATGCATGTCTTTACTTAATCCTGGTGTTTCTATCCTTA GGAAATAGAGCTTAACATTAATATATGCATATATTTTTTTACATGTAGGATTCTAGTTTCTATCTTCTGAGCTCAAGAAAGCTAAACTCAACAAACAGGGTAAAAATCTTCAACTCTCGCCTCAAATT CAATGGTCCTTTGTCCTGACAAAAGTTAGACTTGTCTAATAAGCTGGTATTTTTAGGGCATGATACCCTCCCATTAAGTACTTAAACTACCACGGCAGAGATAGGAAACCTAAGCTTTGCCCCATGGT GAAGTAAAGAACAAAAGCCCCCTTGCCCCAGATCTCTAGCATGACTTGTAAAGTCTTCCTCGGCTCACAGCTTCACTGTTACTGGTCACCTCCTAACTGCTCTGTCCACCTGTACTGTCACACACCTG GAGAGGCAGGGCAGCCCTGCAAGTAAAGGACGCCCAGAGTGGAGCCCCTGGGCAGGCAGCACTCACTCCTGTGGCTCTAGTGATTGTCCATCTGTATGTGGAAAGTCAGGAAGCTGAAGTGCCCAAGA GAAATCATGAATCGCTGATGACACTGTAACAGAAATGCCCTTTGAAGCAGCTATAACTCATGCAATGAGTTTTAAAAACAGAGACTGGTTTTAATCTTTGAAAACAATGTCTGGTTCGTCAGAATGTT TGTTGCTGTTCTTCCCCACCCATTATTTGTATGACATAACCACTGTGACAGGGTGCAGTGTCTCTTCGCCCCCCCAGGATTTTCCTAGTAGTTTCTGTTAGGACAGCTGCCACGGCAGATCCTCCTAA GACAGCAGCAGAGCGGTGGACGTGTGCCTGCAGAGCGGTGGAAAGGGTGATCGGTGGGCAGCTCATCTAATGCCAGCACATTTGACTCTTGTCCTTGACTCGGGCTGAATAACGAGGTTGAAATATGG ATTTGGGAGAGCAACAGGCTATGGAATGATGACGAAGACTGTCATTTCAAACAAAGCAAAAGAAACAGGTTTTCTACCCCCACCTTGCTATGACACATGGAGCTGTGTGCTAGCTGAAATGGGCTGTC AGAAGTGACTGTGGGGACTGAGCACCTCTACTAACATTTCTTGTCTGTCCTAGCATCCTTTCTACTTCTAACGAGTCATTCTTTTGCTTTAAATGAAGTGAAGAATGATGAGTAACAGAGGGACGACA TAGCAGTAGGAAAAAGACCTAAAGTGCACCAACCCCTTGCAGGGCTCAGCTGATTTCTGTGAAATAAACTATTTTAAATGTTAATTATGCTAAGAGCACCTCTAAAAATTATGTCTTAAATTTCAAGT TTCACTTTTGGAAACTACTCCTGAAAAGACATTGAATATAGGTGGGAAAGTATAAAATGTTTCTGACACAATGACTCAGTATTATTCAGTGTTTAATCTCAAATTCGTTATAACACAAGTGTCATCAG TGGGTTAAAACGTTGGATGTTTTTGTTAATATACTTAAAACTGTAACCAGTGAATAACACCGTAGTATTTTTTATTATAGATTATATTTTATTTCAATAAACTTTGATATTTAGACTGAAAA
hide sequence
RefSeq Acc Id:
XP_343421 ⟸ XM_343420
- Peptide Label:
isoform X1
- Sequence:
MENGPDSPQPLELGVPAGRVSTPEGRRRDGREAEDGPAGRAVDSGGQGAAAARSSLGDPTSPSQHGCSAGSDLKNSASSSPVASEAPSRGQHKVTASPELAEAAAGRGSGPVGDTGTCRVEQAAEEPS SAGALSSSCSEPSPPGDSPSLDSLESFSNLHSFPSSSEFNSEEGAETRVPEDVEEGAAEPPRVAPLCKEEEEDPAQVLAASKERFPGQSVYHIKWIQWKEENTPIITQNENGPCPLLAILNVLLLAWK VKLPPMMEIITAEQLMEYLGDYMLEAKPKEISEIQRVNYEQNMSDAMAILHKLQTGLDVNVRFTGVRVFEYTPECIVFDLLDIPLYHGWLVDPQIDDIVRAVGNCSYNQLVEKIISCKQSDNSQLVSE GFVAEQFLNNTATQLTYHGLCELTSTVQEGELCVFFRNNHFSTMTKYKGQLYLLVTDQGFLTEEKIVWESLHNVDGDGNFCDSEFRLRPPSDPETVYKGQQDQIDQDYLMALSLQQEQQSQDINWEQI PEGISDLELAKKLQEEEDRRASQYYQEQEQAQAAVATTTPSTQAQQGQPAQASPSSIKQPGNSERKRKEPREKDKEKEKEKNSCVIL
hide sequence
RefSeq Acc Id:
XP_017451576 ⟸ XM_017596087
- Peptide Label:
isoform X2
- Sequence:
MENGPDSPQPLELGVPAGRVSTPEGRRRDGREAEDGPAGRAVDSGGQGAAAARSSLGDPTSPSQHGCSAGSDLKNSASSSPVASEAPSRGQHKVTASPELAEAAAGRGSGPVGDTGTCRVEQAAEEPS SAGALSSSCSEPSPPGDSPSLDSLESFSNLHSFPSSSEFNSEEGAETRVPEDVEEGAAEPPRVAPLCKEEEEDPAQVLAASKERFPGQSVYHIKWIQWKEENTPIITQNENGPCPLLAILNVLLLAWK VKLPPMMEIITAEQLMEYLGDYMLEAKPKEISEIQRVNYEQNMSDAMAILHKLQTGLDVNVRFTGVRVFEYTPECIVFDLLDIPLYHGWLVDPQIDDIVRAVGNCSYNQLVEKIISCKQSDNSQLVSE GFVAEQFLNNTATQLTYHGLCELTSTVQEGELCVFFRNNHFSTMTKYKGQLYLLVTDQGFLTEEKIVWESLHNVDGDGNFCDSEFRLRPPSDPETVYKGQQDQIDQDYLMALSLQQEQQSQDINWEQI PEGISDLELAKKLQEEEDRRASQYYQEQEQAQAAVATTTPSTQAQKQLREERFVVTYGRGCSSSWS
hide sequence
Ensembl Acc Id:
ENSRNOP00000070456 ⟸ ENSRNOT00000078685
RefSeq Acc Id:
XP_038938431 ⟸ XM_039082503
- Peptide Label:
isoform X3
- UniProtKB:
A6KES6 (UniProtKB/TrEMBL)
Ensembl Acc Id:
ENSRNOP00000082611 ⟸ ENSRNOT00000119592
Ensembl Acc Id:
ENSRNOP00000083544 ⟸ ENSRNOT00000094906
RGD ID: 13696111
Promoter ID: EPDNEW_R6632
Type: initiation region
Name: Mindy2_1
Description: MINDY lysine 48 deubiquitinase 2
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 8 77,089,079 - 77,089,139 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2017-02-09
Mindy2
MINDY lysine 48 deubiquitinase 2
Fam63b
family with sequence similarity 63, member B
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2008-10-16
Fam63b
family with sequence similarity 63, member B
RGD1311456
similar to RIKEN cDNA B230380D07
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2008-04-30
RGD1311456
similar to RIKEN cDNA B230380D07
RGD1311456_predicted
similar to RIKEN cDNA B230380D07 (predicted)
'predicted' is removed
2292626
APPROVED
2005-01-20
RGD1311456_predicted
similar to RIKEN cDNA B230380D07 (predicted)
LOC363089_predicted
Symbol and Name status set to approved
1331353
APPROVED
2005-01-12
LOC363089_predicted
similar to RIKEN cDNA B230380D07 (predicted)
Symbol and Name status set to provisional
70820
PROVISIONAL